PP Influence of sacubitril/ valsartan on biochemical markers in patients with chronic heart failure after COVID-19

被引:0
|
作者
Minovarova, C. [1 ]
Atadjanova, G. [1 ]
Uzokov, J. [2 ]
Tursunov, J. [3 ]
机构
[1] Tashkent Paediat Med Inst, Tashkent, Uzbekistan
[2] Republican Specialized Sci Pract Med Ctr Therapy, Tashkent, Uzbekistan
[3] JackSoft Clin, Tashkent, Uzbekistan
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
58ASM - 14
引用
收藏
页数:1
相关论文
共 50 条
  • [41] An Economic Evaluation of Sacubitril/Valsartan for Heart Failure Patients in the Netherlands
    van der Pol, Simon
    Degener, Fabian
    Postma, Maarten J.
    Vemer, Pepijn
    VALUE IN HEALTH, 2017, 20 (03) : 388 - 396
  • [42] The Efficacy and Safety of Sacubitril/Valsartan in Heart Failure Patients: A Review
    Zhang, Rui
    Sun, Xiaotong
    Li, Ya
    He, Wenzheng
    Zhu, Hongguang
    Liu, Baoshan
    Zhang, Aiyuan
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2022, 27
  • [43] Impact of Sacubitril/Valsartan on Circulating microRNA in Patients with Heart Failure
    Brioschi, Maura
    D'Alessandra, Yuri
    Mapelli, Massimo
    Mattavelli, Irene
    Salvioni, Elisabetta
    Eligini, Sonia
    Mallia, Alice
    Ricci, Veronica
    Gianazza, Erica
    Ghilardi, Stefania
    Agostoni, Piergiuseppe
    Banfi, Cristina
    BIOMEDICINES, 2023, 11 (04)
  • [44] Should All Heart Failure Patients Be Treated With Sacubitril/Valsartan?
    Blankfield, Robert P.
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2018, 23 (01) : 98 - 98
  • [45] Evaluation of Sacubitril/Valsartan Initiation in Outpatient Heart Failure Patients
    Rerick, Lindsey
    Elston, Colleen
    Kester, Jordan
    Montepara, Courtney
    Gengler, Brooke
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2021, 77 (03) : 343 - 348
  • [46] A Retrospective Analysis of Sacubitril/Valsartan in Heart Failure and Chronic Kidney Disease
    McFarland, Kayla L.
    Sheridan, Erica A.
    JOURNAL OF PHARMACY TECHNOLOGY, 2023, 39 (03) : 117 - 122
  • [47] Impact of sacubitril/valsartan on cardiac and systemic hypoxia in chronic heart failure
    Nougue, Helene
    Picard, Francois
    Cohen-Solal, Alain
    Logeart, Damien
    Launay, Jean-Marie
    Vodovar, Nicolas
    ISCIENCE, 2024, 27 (01)
  • [48] Sacubitril/Valsartan: A Review in Chronic Heart Failure with Reduced Ejection Fraction
    McCormack, Paul L.
    DRUGS, 2016, 76 (03) : 387 - 396
  • [49] Haemodynamic Effects of Sacubitril/Valsartan Initiation in Outpatients with Chronic Heart Failure
    Froehlich, Hanna
    Frey, Norbert
    Estler, Bent
    Maeck, Mirjam
    Schlegel, Philipp
    Beckendorf, Jan
    Frankenstein, Lutz
    Taeger, Tobias
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2022, 22 (06) : 695 - 704
  • [50] Haemodynamic Effects of Sacubitril/Valsartan Initiation in Outpatients with Chronic Heart Failure
    Hanna Fröhlich
    Norbert Frey
    Bent Estler
    Mirjam Mäck
    Philipp Schlegel
    Jan Beckendorf
    Lutz Frankenstein
    Tobias Täger
    American Journal of Cardiovascular Drugs, 2022, 22 : 695 - 704